Markets
Bull by the horns
(Getty Images)

S&P 500 books a fresh record closing high ahead of Nvidia earnings

A milestone before the big event.

Nia Warfield, Luke Kawa
8/27/25 3:21PM

The S&P 500 finished with a record close on Wednesday, up 0.2%. The Nasdaq 100 rose 0.2% and the Russell 2000 outperformed with a 0.6% advance.

Energy was the best-performing S&P 500 sector ETF, up more than 1% while healthcare and industrials were the only (very modest) groups to finish in the red.

Gains on the day were led by Albemarle, which jumped 7.5% after Bank of America reiterated its “buy” rating on the stock and set an $84 price target. Declines were led in part by J.M. Smucker, which fell 4.3% after the pantry giant’s fiscal Q1 results undershot Wall Street expectations. Elsewhere…

MongoDB jumped 38% after the database software company posted much better-than-expected fiscal Q2 results before the bell on Wednesday.

Kohl’s shares surged 24% after the department store chain posted blowout second-quarter earnings and tightened its full-year forecast.

Canada Goose shares soared 16.1% following reports that controlling shareholder Bain Capital is exploring a sale of the luxury parka maker.

American Eagle shares rebounded, climbing 8.6% after announcing a collaboration with Kansas City Chiefs tight end Travis Kelce (aka Taylor Swift’s fiancé) through his Tru Kolors clothing brand. Meanwhile, Signet Jewelers gained 6.3%, extending Tuesday’s brief pop on the stars’ engagement news.

Cracker Barrel shares jumped 8% after the Southern-themed restaurant chain switched its logo back to the original design following a flood of backlash from fans.

Krispy Kreme shares fell 3.5% after JPMorgan downgraded its rating on the stock to “underweight” (sell) from “neutral,” citing doubts about the company’s turnaround strategy.

Abercrombie & Fitch shares dipped 1.3% after the mall retailer posted a Q2 beat and hiked its full-year forecast while warning of a bigger tariff hit.

PayPal shares fell in premarket trading but closed largely flat following reports that the fintech company faced payment disruptions in Germany.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.